Overactive Bladder - Results from #2420

Botulinum toxin A submucosal injection for refractory non-neurogenic overactive bladder: Early outcomes - Abstract April 25, 2011

Sacral neuromodulation for treating neurogenic bladder dysfunction: Clinical and urodynamic study - Abstract April 22, 2011

Percutaneous radiofrequency sacral rhizotomy in the treatment of neurogenic detrusor overactivity in spinal cord injured patients - Abstract April 21, 2011

NAFC research on overactive bladder and nocturia published April 21, 2011

Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: A systematic review of the literature - Abstract April 20, 2011

Pharmacotherapy of overactive bladder: Epidemiology and pathophysiology of overactive bladder - Abstract April 19, 2011

Antimuscarinics for the treatment of overactive bladder: Understanding the role of muscarinic subtype selectivity - Abstract April 18, 2011

Once-daily trospium chloride 60 mg extended-release provides effective, long-term relief of overactive bladder syndrome symptoms - Abstract April 15, 2011

Development and pilot testing of a self-management internet-based program for older adults with overactive bladder - Abstract April 14, 2011

Urethral sphincter EMG-controlled dorsal penile/clitoral nerve stimulation to treat neurogenic detrusor overactivity - Abstract April 13, 2011

How does neuromodulation work: ICI-RS 2010? - Abstract April 12, 2011

Effect of fesoterodine 4 mg on bladder diary and patient-reported outcomes during the first week of treatment in subjects with overactive bladder - Abstract April 7, 2011

Etiology and pathogenesis of overactive bladder - Abstract April 4, 2011

Adherence junctions and cadherin-11 in normal and overactive human detrusor smooth muscle cells - Abstract April 1, 2011

Cost-effectiveness of sacral neuromodulation compared to botulinum neurotoxin A or continued medical management in refractory overactive bladder - Abstract March 28, 2011

Functional MRI of the brain in women with overactive bladder: Brain activation during urinary urgency - Abstract March 25, 2011

Adverse event assessment of antimuscarinics for treating overactive bladder: A network meta-analytic approach - Abstract March 24, 2011

TheraVida announces positive results from a phase 1 trial of THVD-201 for overactive bladder at the 2011 Annual Congress of the European Association of Urology March 24, 2011

Idiopathic Parkinson's disease patients at the urologic clinic - Abstract March 23, 2011

The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: Results from EpiLUTS - Abstract March 22, 2011

Page 122 of 123